These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18957179)

  • 1. The CNS as a therapeutic target in multiple sclerosis.
    Antel JP
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):445-7. PubMed ID: 18957179
    [No Abstract]   [Full Text] [Related]  

  • 2. The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
    Hukkanen V; Nygårdas M
    Immunotherapy; 2013 Sep; 5(9):911-3. PubMed ID: 23998724
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissecting the damaging versus regenerative roles of CNS macrophages: implications for the use of immunomodulatory therapeutics.
    Miron VE
    Regen Med; 2013 Nov; 8(6):673-6. PubMed ID: 24147520
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.
    Hunter SF; Rodriguez M
    Springer Semin Immunopathol; 1995; 17(1):89-105. PubMed ID: 7482229
    [No Abstract]   [Full Text] [Related]  

  • 5. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-based therapies for MS: how do we get there from here?
    Kivisäkk P; Trebst C; Eckstein DJ; Kerza-Kwiatecki AP; Ransohoff RM
    Trends Immunol; 2001 Nov; 22(11):591-3. PubMed ID: 11698200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New directions in multiple sclerosis therapy: matching therapy with pathogenesis.
    Antel J
    Can J Neurol Sci; 2010 Sep; 37 Suppl 2():S42-8. PubMed ID: 21246934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for multiple sclerosis.
    Owens T
    Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.
    Webb LM; Guerau-de-Arellano M
    Trends Mol Med; 2017 Jun; 23(6):546-562. PubMed ID: 28478950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies.
    Wright BR; Warrington AE; Edberg DD; Rodriguez M
    Arch Neurol; 2009 Dec; 66(12):1456-9. PubMed ID: 20008649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
    Vries HE; Schwaninger M
    Biochim Biophys Acta; 2016 Mar; 1862(3):297-8. PubMed ID: 26748252
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
    Zweiman B; Lisak RP
    Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
    [No Abstract]   [Full Text] [Related]  

  • 13. Oligodendrocyte precursor cells in chronic multiple sclerosis lesions.
    Wolswijk G
    Mult Scler; 1997 Apr; 3(2):168-9. PubMed ID: 9291175
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells and microglia as drivers of multiple sclerosis pathology.
    Friese MA; Fugger L
    Brain; 2007 Nov; 130(Pt 11):2755-7. PubMed ID: 17956912
    [No Abstract]   [Full Text] [Related]  

  • 16. The essential role of T cells in multiple sclerosis: a reappraisal.
    Constantinescu CS; Gran B
    Biomed J; 2014; 37(2):34-40. PubMed ID: 24732657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis - a response-to-damage model.
    't Hart BA; Hintzen RQ; Laman JD
    Trends Mol Med; 2009 Jun; 15(6):235-44. PubMed ID: 19451035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
    Steinman L; Martin R; Bernard C; Conlon P; Oksenberg JR
    Annu Rev Neurosci; 2002; 25():491-505. PubMed ID: 12052918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemokines in the pathogenesis of multiple sclerosis.
    Woodroofe N; Cross AK; Harkness K; Simpson JE
    Adv Exp Med Biol; 1999; 468():135-50. PubMed ID: 10635025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.